Generated by AI
Cibus Inc. Class A Common Stock represents ownership in Cibus Inc., an agricultural biotechnology company based in San Diego, California. The company develops and licenses gene-edited plant traits for seed companies, using proprietary technologies to improve crop productivity, resilience, and sustainability. Its work centers on traits that can help address challenges such as yield performance, disease pressure, weed control, nutrient use, and climate stress across major crops including canola, rice, soybean, corn, and wheat. Cibus also develops plant traits for sustainable ingredients and other agricultural applications that support lower-input farming and more efficient production systems. As a publicly traded equity security, Cibus Inc. Class A Common Stock provides market participants with exposure to a company focused on agricultural innovation, crop trait development, and commercial licensing within the biotechnology sector.
Website6455 Nancy Ridge Drive
San Diego, CA, 92121
United States
The latest articles about CBUS.
Cibus Inc (CBUS) reported Q3 2026 revenue of $0.8 million and a net loss of $21.9 million, while advancing partner-funded programs and extending its cash runway into early Q1 2027.
Summary of Mar 17's posts. Generated by AI.
Summary of Feb 17's posts. Generated by AI.
No summary yet.
Summary of Feb 17's posts. Generated by AI.
Investors talking about CBUS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.